Steroid Management for Pneumonitis

Treatment Algorithm Based on Pneumonitis Severity

For patients with grade 1 pneumonitis, the American Society of Clinical Oncology recommends considering holding immune checkpoint inhibitor therapy, with oral steroids such as prednisone 1 mg/kg daily or equivalent, and monitoring symptoms and oxygen saturation every 2-3 days with weekly clinic visits 1, 2
For patients with grade 2 pneumonitis, the Society for Immunotherapy of Cancer recommends holding ICI therapy, considering hospitalization with pulmonary and infectious disease consultation, and initiating methylprednisolone 1 mg/kg/day (IV or oral equivalent) 1, 2
For patients with grade 3-4 pneumonitis, the European Society for Medical Oncology recommends permanently discontinuing ICI therapy, hospitalizing the patient, and initiating high-dose IV corticosteroids (methylprednisolone 2-4 mg/kg/day) 1, 2

Special Considerations

For non-infectious pneumonitis, the American College of Chest Physicians recommends treatment interruption and dose reduction for grade 2 symptomatic NIP, and systemic steroids and treatment discontinuation for grade 3 or greater toxicity 3
For COVID-19 pneumonitis, the Infectious Diseases Society of America recommends short-course low-dose steroids in early stages, and systematic corticosteroids (methylprednisolone <1-2 mg/kg body weight for 3-5 days) for severe cases 4
For community-acquired pneumonia, the American Thoracic Society recommends against routine use of steroids in non-severe CAP, and considers their use in severe CAP patients with septic shock refractory to fluid resuscitation and vasopressors 5, 6, 7, 8

Important Considerations and Pitfalls

The American Society of Clinical Oncology recommends always ruling out infection before initiating immunosuppressive treatment, especially in grade 2 or higher pneumonitis 1
The Society for Immunotherapy of Cancer recommends considering prophylactic antibiotics for pneumocystis pneumonia for patients receiving ≥20 mg methylprednisolone or equivalent for ≥4 weeks, and calcium and vitamin D supplementation with prolonged steroid use 2
The American College of Gastroenterology recommends proton pump inhibitor therapy for GI prophylaxis in all patients with grade 2-4 pneumonitis receiving steroids 2
The American Diabetes Association recommends monitoring for steroid-related complications including hyperglycemia and increased risk of secondary infections 5, 6, 7
The European Society for Medical Oncology recommends careful monitoring for relapses of pneumonitis during steroid tapering 1

Steroid Dosing Guidelines for Severe Pneumonia

Evidence-Based Dosing Recommendations

The Military Medical Research recommends not to exceed methylprednisolone equivalent to 1-2 mg/kg/day for severe pneumonia 9
The Intensive Care Medicine guidelines advise against using high-dose steroids (hydrocortisone ≥300 mg/day or prednisolone ≥75 mg/day) as they increase hospital-acquired infections, hyperglycemia, and gastrointestinal bleeding without mortality benefit 10
Short courses of 3-5 days are recommended according to degree of dyspnea and chest imaging progression, and routine or prolonged corticosteroid use should be avoided unless specifically indicated 9
For Pneumocystis jiroveci pneumonia with hypoxemia, the Intensive Care Medicine guidelines recommend prednisolone 2×40 mg/day for 5 days, then 1×40 mg/day for 5 days, then 1×20 mg for 10 days 10

Critical Safety Monitoring and Pitfalls

The Journal for ImmunoTherapy of Cancer recommends proton pump inhibitor therapy for GI prophylaxis in all patients receiving steroids for grade 2-4 pneumonitis 11
The Military Medical Research and Intensive Care Medicine guidelines warn against using high-dose steroids (>2 mg/kg/day methylprednisolone equivalent) as it increases complications without improving mortality, and prolonged courses beyond 5-10 days increase infection risk and other complications 9, 10
The Intensive Care Medicine guidelines advise against starting steroids before adequate fluid resuscitation in septic shock 10
The Journal for ImmunoTherapy of Cancer recommends considering Pneumocystis pneumonia prophylaxis for patients receiving ≥20 mg methylprednisolone equivalent for ≥4 weeks, and calcium and vitamin D supplementation with prolonged steroid use 11

Steroid Dosing for Severe Pneumonia

Introduction to Steroid Use

The American College of Critical Care Medicine recommends methylprednisolone 1-2 mg/kg/day (or equivalent hydrocortisone <400 mg/day, or dexamethasone 6 mg daily) for 5-7 days in patients with severe community-acquired pneumonia, particularly those with high inflammatory markers or septic shock refractory to fluids and vasopressors 12

Specific Dosing Recommendations by Agent

Methylprednisolone should be dosed at 1-2 mg/kg/day IV for 3-5 days in severe pneumonia with rapid deterioration 13
Dexamethasone should be given at 6 mg once daily (oral or IV) for up to 10 days in severe pneumonia requiring oxygen, with a shown 35% mortality reduction in mechanically ventilated patients and 20% reduction in those on supplemental oxygen 13
Hydrocortisone should be used at <400 mg/day IV (stress-dose equivalent: 200-300 mg/day) for 5-7 days, particularly for vasopressor-dependent septic shock with pneumonia 12

Treatment Duration and Tapering

A standard course of 5-7 days is recommended for severe community-acquired pneumonia 12
Tapering should be done slowly over 2-4 months if treatment extends beyond a few days to prevent rebound phenomenon 13

Clinical Context for Use

Steroids should be used in severe CAP with CRP >150 mg/L or septic shock refractory to fluid resuscitation and vasopressors 12
Patients requiring mechanical ventilation or high-flow oxygen (FiO2 ≥50%) should also receive steroids 13
Steroids can help prevent ARDS progression (RR 0.24) 12
Influenza pneumonia is a contraindication for steroid use due to increased mortality (OR 3.06 for death) 12
Mild pneumonia not requiring oxygen shows no benefit and possible harm (RR 1.22 for mortality) from steroid use 13

Evidence Quality and Nuances

The 2018 SCCM/ESICM guidelines provide the strongest recommendation, based on 13 trials (n=2005) showing consistent benefits: shortened hospital stay (−3 days), reduced mechanical ventilation need (RR 0.45), and ARDS prevention (RR 0.24) 12
The landmark RECOVERY trial (n=6425) definitively established dexamethasone 6 mg benefit in severe cases 13

Critical Safety Monitoring

PCP prophylaxis (trimethoprim-sulfamethoxazole) is required for patients receiving ≥20 mg methylprednisolone equivalent for ≥4 weeks 14
Proton pump inhibitor is necessary for GI prophylaxis in all patients receiving steroids for grade 2-4 pneumonitis 14
Calcium and vitamin D supplementation is recommended with prolonged steroid use 14
Tight glucose control is necessary as hyperglycemia risk increases (RR 1.49) 12
Monitoring for secondary infections during treatment, particularly bacterial superinfection, is crucial 12
Screening for occult adrenal insufficiency in hypotensive, fluid-resuscitated patients with severe CAP using cortisol stimulation testing is recommended 15

Steroid Therapy in Severe Pneumonia

Introduction to Steroid Therapy

The American College of Physicians recommends using methylprednisolone 1 mg/kg/day (typically 40-80 mg daily, not exceeding 2 mg/kg/day) intravenously for 5-7 days for severe community-acquired pneumonia 16

Critical Dosing Limits and Safety

The Society of Critical Care Medicine warns against exceeding 2 mg/kg/day methylprednisolone equivalent, as higher doses increase hospital-acquired infections, hyperglycemia, and gastrointestinal bleeding without mortality benefit 16

Essential Supportive Measures During Steroid Therapy

Tight glucose control is necessary as hyperglycemia risk increases (RR 1.49), though mostly within 36 hours following initial bolus, according to the European Society of Intensive Care Medicine 17
Infection surveillance is crucial as glucocorticoids blunt febrile response - monitor for bacterial superinfection, as recommended by the European Society of Intensive Care Medicine 17

Common Pitfalls to Avoid

The Infectious Diseases Society of America recommends against routine use of steroids in non-severe CAP, and warns against rapid or abrupt discontinuation - always taper slowly to prevent rebound inflammation, according to the Infectious Diseases Society of America 18
The European Society of Intensive Care Medicine advises against starting steroids before ruling out infection, especially in immunocompromised patients, and recommends monitoring for hyperglycemia especially within first 36 hours after initial bolus 17

Infection Assessment and Steroid Tapering in Patients with New Pneumonia While on a Prior Steroid Regimen

Infection Evaluation Before Escalating Immunosuppression

Obtain microbiological cultures, chest imaging, and consider bronchoscopy when the underlying cause of the new pneumonia is unclear, especially in patients with grade 2 or higher severity, before increasing steroid dosing or adding additional immunosuppressive agents. 19

Tapering Recommendations After Pneumonia Resolution

After successful treatment of pneumonia, avoid rapid steroid tapering; implement a minimum taper duration of 4–6 weeks to reduce the risk of symptom recrudescence and adrenal insufficiency. 19